SEQ ID NO:1 of Patent CN111225679A

General Information


DRACP ID  DRACP06104

Peptide Name   SEQ ID NO:1 of Patent CN111225679A

Sequence  TLPNSNHIKQGL

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Not available

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C57H96N18O18

Absent amino acids  ACDEFMRVWY

Common amino acids  LN

Mass  151789

Pl  9.7

Basic residues  2

Acidic residues  0

Hydrophobic residues  3

Net charge  2

Boman Index  -1930

Hydrophobicity  -75

Aliphatic Index  97.5

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN111225679A

Patent Title  Novel Peptide-Based Cancer Imaging Agents

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.